Scandinavian ChemoTech AB’s Board of Directors and management team exercise warrants of series TO3
The Board of Directors and management team in Scandinavian ChemoTech AB (“Scandinavian ChemoTech” or the “Company”) exercise warrants of series TO3. The number of warrants of series TO3 exercised by the Board of Directors and management team amounts to 280,954 TO3, consisting of 200,000 warrants of series TO3A and 80,954 warrants of series TO3B. This corresponds to approximately 11.8 percent of the outstanding warrants of series TO3, equivalent to a subscription of 280,954 shares at a value of approximately 1.35 million SEK."Scandinavian ChemoTech has never been in a more interesting